Mukesh Ambani-backed Reliance Industries has forayed into genome testing and its test kit will be rolled out soon. The kit is developed by the Bengaluru-based Strand Life Sciences, which was acquired by Reliance Industries in 2021 and has 80 per cent stake in the firm.
As per a report from Allied Market Research, the market for global genetic testing was valued at $12.7 billion in 2019 and is anticipated to touch $21.3 billion by 2027
Outlook covers the latest India news, analysis, business news and long-form stories on culture, money market and personal finance. Read India's best online magazine.
Mukesh Ambani's Reliance to roll out genome sequencing kit priced Rs 12,000; all you need to know
The emerging landscape of single-molecule protein sequencing technologies
Reliance Industries
Asia's richest man to enter genetic testing market with $145 kits
Latest & Updated Business News from India & World - Live News
Genes, Free Full-Text
Mukesh Ambani's Reliance to roll out genome sequencing kit priced Rs 12,000; all you need to know
Asia's richest man to enter genetic testing market with $145 kits
Our Research & Development - Reliance Industries